Key issues in the Pharmaceutical sector.

 

A wide range of trends and themes have emerged from our review of January to March 2010 pharmaceutical activity, including cost-cutting and restructuring measures, consolidation and M&A activity, increasing industry collaboration, and entry into emerging markets.

 

All of these trends will have clear implications for the real estate portfolios of pharmaceutical companies across the globe.